Finance

Lists
Why is STAR down ၃.၁၂%?
Dive Deeper
STAR:NSE
Strides Pharma Science Ltd
၁,၀၈၅.၀၀ ₹
-၃.၁၂%
(-၃၅.၀၀) 1D
အောက် ၁, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for STAR...
Open
၁,၁၀၈.၄၀ ₹
High
၁,၁၂၂.၀၀ ₹
Low
၁,၀၇၆.၀၀ ₹
Mkt. cap
ဋေ ၁.၀၀ သ
Avg. vol.
၅.၀၈ သိန်း
Volume
၃.၄၁ သိန်း
Dividend
၀.၄၆%
Quarterly dividend
၁.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၃၁
P/E ratio
၁၆.၃၀
52-wk high
၁,၂၆၀.၉၀ ₹
52-wk low
၇၆၈.၆၅ ₹
EPS
၆၆.၅၅ ₹
Shares outstanding
၈.၉၆ ကုဋေ
No. of employees
၄ ထောင်
Open
၁,၁၀၈.၄၀ ₹
High
၁,၁၂၂.၀၀ ₹
Low
၁,၀၇၆.၀၀ ₹
Mkt. cap
ဋေ ၁.၀၀ သ
Avg. vol.
၅.၀၈ သိန်း
Volume
၃.၄၁ သိန်း
Dividend
၀.၄၆%
Quarterly dividend
၁.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၃၁
P/E ratio
၁၆.၃၀
52-wk high
၁,၂၆၀.၉၀ ₹
52-wk low
၇၆၈.၆၅ ₹
EPS
၆၆.၅၅ ₹
Shares outstanding
၈.၉၆ ကုဋေ
No. of employees
၄ ထောင်
News stories
From web sources and news partners
www.marketscreener.com
www.marketscreener.com
·
ပြီးခဲ့သည့် ၁၃ မိနစ်
Surf Air Mobility Announces Employee Inducement Awards Under NYSE Rule 303A.08
Intellia Therapeutics
Intellia Therapeutics
·
ပြီးခဲ့သည့် ၁၇ မိနစ်
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
GlobeNewswire
·
ပြီးခဲ့သည့် ၁၄ မိနစ်
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CNBC
CNBC
·
ပြီးခဲ့သည့် ၂ နာရီ
Friday's rally in the S&P 500 might not be enough, but Linde is out of this world
Profile
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies. Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
About Strides Pharma Science Ltd
CEO-
Employees၃.၅၄ ထောင်
Founded၁၉၉၀
Headquartersဘန်ဂလိုမြို့, ကာနာတာကာ, အိန္ဒိယ
Sector-
Last report
၂၀၂၆ ဇူ ၃၁
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
ဋေ ၁.၂၇ ထ / ဋေ ၁.၃၃ ထ
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၂၂ ထ
ဋေ ၁.၁၉ ထ
ဋေ ၁.၃၂ ထ
ဋေ ၁.၂၇ ထ
Cost of goods sold
၅၁၅.၂၆ ဋေ
၄၆၂.၉၄ ဋေ
၇၁၉.၂၁ ဋေ
၄၉၅.၁၉ ဋေ
Cost of revenue
၅၁၅.၂၆ ဋေ
၄၆၂.၉၄ ဋေ
၇၁၉.၂၁ ဋေ
၄၉၅.၁၉ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၂၆.၇၈ ဋေ
၂၂၉.၅၄ ဋေ
၃၄၄.၈၆ ဋေ
၂၄၂.၉၉ ဋေ
Operating expense
၅၂၃.၆၅ ဋေ
၅၄၆.၃၈ ဋေ
၄၉၀.၉၆ ဋေ
၅၉၆.၈၄ ဋေ
Total operating expenses
ဋေ ၁.၀၄ ထ
ဋေ ၁.၀၁ ထ
ဋေ ၁.၂၁ ထ
ဋေ ၁.၀၉ ထ
Operating income
၁၈၁.၉၂ ဋေ
၁၈၅.၃၂ ဋေ
၁၁၃.၃၀ ဋေ
၁၇၃.၃၈ ဋေ
Other non operating income
၂၇.၁၄ ကုဋေ
၁၀၆.၈၆ ဋေ
-၁၆၆.၃၇ ဋေ
၄.၈၉ ကုဋေ
EBT including unusual items
၁၅၃.၁၂ ဋေ
၂၄၅.၄၈ ဋေ
၁၄၈.၀၅ ဋေ
၁၉၉.၆၂ ဋေ
EBT excluding unusual items
၁၆၁.၈၉ ဋေ
၂၄၈.၇၇ ဋေ
၅၀.၂၁ ကုဋေ
၁၃၆.၄၂ ဋေ
Income tax expense
၂၁.၅၉ ကုဋေ
၃၇.၃၅ ကုဋေ
၁၈.၇၇ ကုဋေ
၃၄.၁၂ ကုဋေ
Effective tax rate
၁၄.၁၀%
၁၅.၂၂%
၁၂.၆၈%
၁၇.၀၉%
Other operating expenses
၂၄၇.၂၂ ဋေ
၂၆၆.၂၂ ဋေ
၉၂.၈၅ ကုဋေ
၂၉၇.၄၆ ဋေ
Net income
၁၂၇.၅၃ ဋေ
၂၀၂.၁၁ ဋေ
၁၂၆.၉၄ ဋေ
၁၅၆.၉၁ ဋေ
Net profit margin
၁၀.၄၅%
၁၆.၉၂%
၉.၅၉%
၁၂.၄၀%
Earnings per share
-
-
-
-
Interest and investment income
-
-
၄၀.၄၈ ကုဋေ
-
Interest expense
-၄၆.၁၃ ကုဋေ
-၄၃.၃၈ ကုဋေ
-၁၃.၀၈ ကုဋေ
-၄၀.၅၆ ကုဋေ
Net interest expenses
-၄၆.၁၃ ကုဋေ
-၄၃.၃၈ ကုဋေ
၂၇.၄၀ ကုဋေ
-၄၀.၅၆ ကုဋေ
Depreciation and amortization charges
၄၉.၆၄ ကုဋေ
၅၀.၆၂ ကုဋေ
၅၃.၂၅ ကုဋေ
၅၆.၄၀ ကုဋေ
EBITDA
၂၃၁.၁၉ ဋေ
၂၂၅.၂၁ ဋေ
၁၅၄.၅၁ ဋေ
၂၁၄.၅၈ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ